News

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
"Here is a prime example of just how influential Big Pharma still is," MAHA influencer Diana Atieh told Newsweek.
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Dr. Peter Chin Hong, a Bay Area infectious disease expert, discusses the stricter policy from the Food and Drug ...